Literature DB >> 12379696

Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice.

Wim Noël1, Gholamreza Hassanzadeh, Geert Raes, Boniface Namangala, Inge Daems, Lea Brys, Frank Brombacher, Patrick De Baetselier, Alain Beschin.   

Abstract

The contribution of cytokines and chemokines to resistance and susceptibility to African trypanosomiasis remains controversial. In the present study, the levels of type I and type II cytokines and of the MCP-1 chemokine were compared during the early and late stages of Trypanosoma congolense infection in susceptible BALB/c and resistant C57BL/6 mice. Moreover, the status of macrophage activation was compared in these animals by analyzing the inducible nitric oxide synthase-arginase balance, tumor necrosis factor secretion, and expression of the FIZZ1 and YM genes. Data show that changing from a predominant type I cytokine environment in the early stage of infection to a predominant type II cytokine environment and an enhanced MCP-1 secretion in the late stage of infection correlates with resistance to T. congolense. Concomitantly, macrophage activation evolves from a classical to a predominant alternative phenotype. We further confirmed that the simultaneous occurrence of type I/type II cytokines in the early stage of infection in susceptible BALB/c mice, reflected by the presence of macrophages exhibiting a mixed classical/alternative activation phenotype, is associated with uncontrolled parasite growth and early death. Interleukin-4 (IL-4) and IL-13 signaling did not influence the susceptibility of BALB/c mice to T. congolense infection and interestingly were not the main trigger to alternative macrophage activation. In T. congolense-resistant C57BL/6 mice, our results corroborated the induction of FIZZ1 and YM gene expressions with the alternative pathway of macrophage activation. In susceptible BALB/c mice, however, YM but not FIZZ1 induction reflected the emergence of alternatively activated macrophages. Hence, the FIZZ1 and YM genes may be useful markers to discriminate between distinct populations of alternatively activated macrophages.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379696      PMCID: PMC130440          DOI: 10.1128/IAI.70.11.6180-6187.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Upregulation of the chemokines Rantes, MCP-1, MIP-1a and MIP-2 in early infection with Trypanosoma brucei brucei and inhibition by sympathetic denervation of the spleen.

Authors:  Y Liu; Z Li; M Bakhiet
Journal:  Trop Med Int Health       Date:  1999-02       Impact factor: 2.622

2.  Resistance to the African trypanosomes is IFN-gamma dependent.

Authors:  C J Hertz; H Filutowicz; J M Mansfield
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

3.  Expression of the Ym2 lectin-binding protein is dependent on interleukin (IL)-4 and IL-13 signal transduction: identification of a novel allergy-associated protein.

Authors:  D C Webb; A N McKenzie; P S Foster
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

4.  Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis.

Authors:  B Namangala; W Noël; P De Baetselier; L Brys; A Beschin
Journal:  J Infect Dis       Date:  2001-05-15       Impact factor: 5.226

5.  Innate resistance to Trypanosoma congolense infections: differential production of nitric oxide by macrophages from susceptible BALB/c and resistant C57Bl/6 mice.

Authors:  R S Kaushik; J E Uzonna; J R Gordon; H Tabel
Journal:  Exp Parasitol       Date:  1999-06       Impact factor: 2.011

6.  Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages.

Authors:  Geert Raes; Patrick De Baetselier; Wim Noël; Alain Beschin; Frank Brombacher; Gholamreza Hassanzadeh Gh
Journal:  J Leukoc Biol       Date:  2002-04       Impact factor: 4.962

7.  A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection.

Authors:  F H Falcone; P Loke; X Zang; A S MacDonald; R M Maizels; J E Allen
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

8.  Interleukin 4 is a crucial cytokine in controlling Trypanosoma brucei gambiense infection in mice.

Authors:  N Inoue; M Inoue; K Kuriki; H Yamaguchi; H Nagasawa; T Mikami; K Fujisaki; N Suzuki; H Hirumi
Journal:  Vet Parasitol       Date:  1999-10-01       Impact factor: 2.738

9.  Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity.

Authors:  W L Dempsey; J M Mansfield
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

10.  Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice.

Authors:  B Lu; B J Rutledge; L Gu; J Fiorillo; N W Lukacs; S L Kunkel; R North; C Gerard; B J Rollins
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

View more
  19 in total

1.  Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages.

Authors:  Sheila Donnelly; Sandra M O'Neill; Mary Sekiya; Grace Mulcahy; John P Dalton
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 2.  Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.

Authors:  Nicolas Antoine-Moussiaux; Philippe Büscher; Daniel Desmecht
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

3.  Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice.

Authors:  Glendie Marcelin; Jerry R Aldridge; Susu Duan; Hazem E Ghoneim; Jerold Rehg; Henju Marjuki; Adrianus C M Boon; Jonathan A McCullers; Richard J Webby
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

4.  Arginase in parasitic infections: macrophage activation, immunosuppression, and intracellular signals.

Authors:  Cinthia C Stempin; Laura R Dulgerian; Vanina V Garrido; Fabio M Cerban
Journal:  J Biomed Biotechnol       Date:  2009-12-09

5.  Common and small molecules as the ultimate regulatory and effector mediators of antigen-specific transplantation reactions.

Authors:  Vladimir Holan; Magdalena Krulova
Journal:  World J Transplant       Date:  2013-12-24

6.  Alternatively Activated Macrophages Revisited: New Insights into the Regulation of Immunity, Inflammation and Metabolic Function following Parasite Infection.

Authors:  Jessica C Jang; Meera G Nair
Journal:  Curr Immunol Rev       Date:  2013-08-01

7.  Role for parasite genetic diversity in differential host responses to Trypanosoma brucei infection.

Authors:  Liam J Morrison; Sarah McLellan; Lindsay Sweeney; Chi N Chan; Annette MacLeod; Andy Tait; C Michael R Turner
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

8.  STAT1 is essential for antimicrobial effector function but dispensable for gamma interferon production during Toxoplasma gondii infection.

Authors:  L Cristina Gavrilescu; Barbara A Butcher; Laura Del Rio; Gregory A Taylor; Eric Y Denkers
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism.

Authors:  Kari Ann Shirey; Leah E Cole; Achsah D Keegan; Stefanie N Vogel
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

10.  The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo.

Authors:  Olga Atochina; Akram A Da'dara; Mirjam Walker; Donald A Harn
Journal:  Immunology       Date:  2008-03-28       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.